Makers of NanoCur

Haus Bioceuticals is a specialty pharmaceutical company focused on the R&D and commercialization of technologies created from clinically-active botanical extracts (bioceuticals). Haus mission is to develop natural medicines using an evidenced-based approach. Haus’s highly integrated R&D team is comprised of multidisciplinary experts in the fields of naturopathic and allopathic medicine, immunology, inflammatory biology, and early-stage brand development and commercialization. Haus utilizes state-of-the-art laboratories for lead compound identification, mechanism of action studies, and preclinical assessments. In addition, Haus has an active clinical trial program to identify indications and quantify efficacy and safety profiles relative to current standards of care. Clinically active botanicals are put through the same rigorous development process as pharmaceutical medicines, bridging the worlds of pharmacologic and naturopathic medicine. This is a unique approach, a third path, where the full potential and mechanisms of action of these natural safe and effective anti-inflammatory treatments is being understood and harnessed in an evidenced-based manner for the first time.